• 1. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

2-Bromo-5-ethoxybenzonitrile (CAS No. 1353776-83-6): An Overview of Its Synthesis, Properties, and Applications in Pharmaceutical Research

2-Bromo-5-ethoxybenzonitrile (CAS No. 1353776-83-6) is a versatile organic compound that has gained significant attention in the fields of organic synthesis and pharmaceutical research. This compound, characterized by its unique molecular structure, exhibits a broad range of chemical and physical properties that make it an essential intermediate in the synthesis of various biologically active molecules. In this article, we will delve into the synthesis, properties, and potential applications of 2-Bromo-5-ethoxybenzonitrile, highlighting recent advancements and research findings.

Synthesis of 2-Bromo-5-ethoxybenzonitrile

The synthesis of 2-Bromo-5-ethoxybenzonitrile can be achieved through several well-documented methods. One common approach involves the bromination of 5-ethoxybenzonitrile using bromine or a brominating agent such as N-bromosuccinimide (NBS). The reaction typically proceeds under mild conditions, yielding high yields of the desired product. Another method involves the coupling of 2-bromobenzonitrile with ethyl alcohol in the presence of a suitable catalyst, such as palladium on carbon (Pd/C) or copper(I) iodide (CuI).

The choice of synthetic route depends on factors such as the availability of starting materials, reaction conditions, and desired purity levels. Recent studies have explored the use of green chemistry principles to develop more environmentally friendly and efficient methods for synthesizing 2-Bromo-5-ethoxybenzonitrile. For instance, a study published in the Journal of Organic Chemistry reported a novel microwave-assisted synthesis that significantly reduced reaction times and improved yields while minimizing waste generation.

Physical and Chemical Properties

2-Bromo-5-ethoxybenzonitrile is a white crystalline solid with a molecular formula of C₉H₉BrNO and a molecular weight of 231.07 g/mol. It is insoluble in water but soluble in common organic solvents such as ethanol, acetone, and dichloromethane. The compound exhibits a melting point of approximately 80°C and a boiling point around 180°C at reduced pressure.

The presence of the bromine atom and the ethoxy group imparts unique chemical reactivity to 2-Bromo-5-ethoxybenzonitrile. The bromine atom serves as an excellent leaving group, making it highly reactive in nucleophilic substitution reactions. The ethoxy group provides additional functionality, allowing for further derivatization through ether cleavage or alkylation reactions. These properties make 2-Bromo-5-ethoxybenzonitrile an attractive starting material for the synthesis of complex organic molecules.

Applications in Pharmaceutical Research

2-Bromo-5-ethoxybenzonitrile has found numerous applications in pharmaceutical research due to its potential as an intermediate in the synthesis of biologically active compounds. One area of significant interest is its use in the development of novel anticancer agents. Recent studies have shown that derivatives of 2-Bromo-5-ethoxybenzonitrile exhibit potent antiproliferative activity against various cancer cell lines. For example, a study published in the Journal of Medicinal Chemistry reported that a series of substituted benzonitriles derived from 2-Bromo-5-ethoxybenzonitrile demonstrated selective cytotoxicity towards breast cancer cells while showing minimal toxicity to normal cells.

Beyond cancer research, 2-Bromo-5-ethoxybenzonitrile has also been explored for its potential applications in neurodegenerative diseases. A study published in Bioorganic & Medicinal Chemistry Letters investigated the use of 2-Bromo-5-ethoxybenzonitrile-based compounds as inhibitors of beta-secretase (BACE1), an enzyme implicated in Alzheimer's disease. The results showed that these compounds effectively inhibited BACE1 activity, suggesting their potential as therapeutic agents for Alzheimer's disease.

Safety Considerations and Handling

2-Bromo-5-ethoxybenzonitrile, it is important to follow standard safety protocols to ensure laboratory safety. The compound should be stored in a cool, dry place away from direct sunlight and incompatible materials. Appropriate personal protective equipment (PPE), including gloves, goggles, and lab coats, should be worn during handling to prevent skin contact and inhalation. In case of accidental exposure, immediate medical attention should be sought.

In conclusion, 2-Bromo-5-ethoxybenzonitrile (CAS No. 1353776-83-6) is a valuable compound with diverse applications in organic synthesis and pharmaceutical research. Its unique chemical properties make it an essential intermediate in the development of novel therapeutic agents for various diseases. Ongoing research continues to uncover new possibilities for its use, further highlighting its significance in modern chemistry and medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)